Is a complete ASX/MYX research report available?

No complete published report is available for asx/MYX (ASX/MYX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/MYX (ASX/MYX)

Australian Securities Exchange: ASX/MYX · AUD

A$2.63

+0.21 (+8.7%)· Recorded snapshot

Market cap	215.4M
Revenue (ttm)	383.7M
Net income (ttm)	24.5M
EPS (ttm)	A$0.21
Shares out	81.9M
P/E (trailing)	12.7x
Volume	109,280
Beta	1.03

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 383.7M
Net income (ttm): 24.5M
EPS (ttm): A$0.21
P/E (trailing): 12.7x
Market cap: 215.4M

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-23
Employees	363
Employees change	-128
Employees growth	-26.07%
Enterprise value	AUD 178.6M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2005
Industry	Medical Distribution
Is primary listing	Yes
ISIN number	AU000000MYX0
Last earnings date	2026-08-27
Last refreshed	2026-10-28
Last stock split date	2023-01-18
Last stock split type	Reverse
Market cap	AUD 215.4M
Next earnings date	2026-11-23
Price	AUD 2.63
Price currency	AUD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	asx/MYX
Website	https://www.maynepharma.com

Metric

Value

Amount currency

AUD

Country

Australia

Country code

Earnings date

2026-11-23

Employees

363

Employees change

-128

Employees growth

-26.07%

Enterprise value

AUD 178.6M

Exchange

Australian Securities Exchange

Financial currency

AUD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

June

Founded

2005

Industry

Medical Distribution

Is primary listing

Yes

ISIN number

AU000000MYX0

Last earnings date

2026-08-27

Last refreshed

2026-10-28

Last stock split date

2023-01-18

Last stock split type

Reverse

Market cap

AUD 215.4M

Next earnings date

2026-11-23

Price

AUD 2.63

Price currency

AUD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

asx/MYX

Website

https://www.maynepharma.com

Metric	Value
Earnings yield	7.89%
EV/Earnings	7.3x
EV/EBITDA	4.94x
EV/FCF	16.35x
EV/Sales	0.47x
FCF / EV yield	6.12%
FCF yield	5.07%
Graham number	4.74075
Graham upside	80.26%
Lynch fair value	AUD 1.04
Lynch upside	-60.53%
P/(FCF - SBC) ratio	33.95x
P/(OCF - SBC) ratio	23.19x
P/B ratio	0.55x
P/E ratio	12.67x
P/FCF ratio	19.72x
P/OCF ratio	15.53x
P/S ratio	0.56x
Price/EBITDA ratio	6.51x
Sector forward P/E	33.76x

Metric

Value

Earnings yield

7.89%

EV/Earnings

7.3x

EV/EBITDA

4.94x

EV/FCF

16.35x

EV/Sales

0.47x

FCF / EV yield

6.12%

FCF yield

5.07%

Graham number

4.74075

Graham upside

80.26%

Lynch fair value

AUD 1.04

Lynch upside

-60.53%

P/(FCF - SBC) ratio

33.95x

P/(OCF - SBC) ratio

23.19x

P/B ratio

0.55x

P/E ratio

12.67x

P/FCF ratio

19.72x

P/OCF ratio

15.53x

P/S ratio

0.56x

Price/EBITDA ratio

6.51x

Sector forward P/E

33.76x

Metric	Value
EBIT margin	-6.92%
EBITDA margin	8.63%
Effective tax rate	12.75%
FCF margin	2.85%
Gross margin	64.66%
Operating margin	-6.92%
Pretax margin	9.32%
Profit margin	6.38%
Profit per employee	AUD 67,419
Profitable quarters	1
Profitable years	1
Revenue per employee	AUD 1.1M
ROA	-1.73%
ROA (5Y)	-4.34%
ROCE	-4.09%
ROE	8.2%
ROE (5Y)	-26.48%
ROIC	-6.55%
ROIC (5Y)	-14.8%
SBC / revenue	1.19%
Tax / revenue	1.19%

Metric

Value

EBIT margin

-6.92%

EBITDA margin

8.63%

Effective tax rate

12.75%

FCF margin

2.85%

Gross margin

64.66%

Operating margin

-6.92%

Pretax margin

9.32%

Profit margin

6.38%

Profit per employee

AUD 67,419

Profitable quarters

Profitable years

Revenue per employee

AUD 1.1M

ROA

-1.73%

ROA (5Y)

-4.34%

ROCE

-4.09%

ROE

8.2%

ROE (5Y)

-26.48%

ROIC

-6.55%

ROIC (5Y)

-14.8%

SBC / revenue

1.19%

Tax / revenue

1.19%

Metric	Value
EPS growth 10Y	-9.97%
EPS growth 3Y	-33.59%
EPS growth quarters	7
EPS growth years	3
FCF growth	110.34%
FCF growth (Q)	-15.99%
FCF growth 5Y	-35.04%
Gross profit growth	0.32%
Gross profit growth (Q)	-5.95%
Gross profit growth 3Y	124.16%
Gross profit growth 5Y	4.73%
Net income growth 3Y	-25.47%
Net income growth quarters	7
Net income growth years	2
OCF growth	-20.61%
OCF growth (Q)	-25.51%
OCF growth 10Y	-11%
OCF growth 5Y	-33.37%
Revenue growth	-5.98%
Revenue growth (Q)	-12.02%
Revenue growth (QoQ)	-19.08%
Revenue growth 10Y	6.26%
Revenue growth 3Y	86.68%
Revenue growth 5Y	-2.64%
Revenue growth years	0

Metric

Value

EPS growth 10Y

-9.97%

EPS growth 3Y

-33.59%

EPS growth quarters

EPS growth years

FCF growth

110.34%

FCF growth (Q)

-15.99%

FCF growth 5Y

-35.04%

Gross profit growth

0.32%

Gross profit growth (Q)

-5.95%

Gross profit growth 3Y

124.16%

Gross profit growth 5Y

4.73%

Net income growth 3Y

-25.47%

Net income growth quarters

Net income growth years

OCF growth

-20.61%

OCF growth (Q)

-25.51%

OCF growth 10Y

-11%

OCF growth 5Y

-33.37%

Revenue growth

-5.98%

Revenue growth (Q)

-12.02%

Revenue growth (QoQ)

-19.08%

Revenue growth 10Y

6.26%

Revenue growth 3Y

86.68%

Revenue growth 5Y

-2.64%

Revenue growth years

Metric	Value
Capital expenditures	AUD -2.9M
Depreciation and amortization	AUD 59.7M
EBIT	AUD -26.6M
EBITDA	AUD 33.1M
EPS	AUD 0.21
FCF per share	AUD 0.13
Financing cash flow	AUD -1.5M
Free cash flow	AUD 10.9M
Free cash flow minus SBC	AUD 6.3M
Gross profit	AUD 248.1M
Income taxes	AUD 4.6M
Investing cash flow	AUD 10M
Net borrowing	AUD -3.2M
Net cash flow	AUD 20.2M
Net income	AUD 24.5M
Operating cash flow minus SBC	AUD 9.3M
Operating income	AUD -26.6M
Revenue	AUD 383.7M
Stock-based compensation	AUD 4.6M

Metric

Value

Capital expenditures

AUD -2.9M

Depreciation and amortization

AUD 59.7M

EBIT

AUD -26.6M

EBITDA

AUD 33.1M

EPS

AUD 0.21

FCF per share

AUD 0.13

Financing cash flow

AUD -1.5M

Free cash flow

AUD 10.9M

Free cash flow minus SBC

AUD 6.3M

Gross profit

AUD 248.1M

Income taxes

AUD 4.6M

Investing cash flow

AUD 10M

Net borrowing

AUD -3.2M

Net cash flow

AUD 20.2M

Net income

AUD 24.5M

Operating cash flow minus SBC

AUD 9.3M

Operating income

AUD -26.6M

Revenue

AUD 383.7M

Stock-based compensation

AUD 4.6M

Metric	Value
Altman Z-Score	-0.79
Book value per share	AUD 4.81
Debt / EBITDA	1.19
Debt / equity	0.11
Debt / FCF	3.95
Interest coverage	-5.01
Long-term assets	AUD 570M
Long-term liabilities	AUD 258.6M
Net cash (debt)	AUD 36.8M
Net cash / market cap	17.09%
Net cash growth	-37.76%
Net debt / EBITDA	-1.11
Net debt / equity	-0.09
Net debt / FCF	-3.37
Piotroski F-Score	4
Property, plant and equipment	AUD 55.1M
Shareholders' equity	AUD 390.9M
Tangible book value	AUD -69.2M
Tangible book value per share	AUD -0.85
Total assets	AUD 909.4M
Total cash	AUD 80M
Total debt	AUD 43.2M
Total liabilities	AUD 518.5M
WACC	10.03%

Metric

Value

Altman Z-Score

-0.79

Book value per share

AUD 4.81

Debt / EBITDA

1.19

Debt / equity

0.11

Debt / FCF

3.95

Interest coverage

-5.01

Long-term assets

AUD 570M

Long-term liabilities

AUD 258.6M

Net cash (debt)

AUD 36.8M

Net cash / market cap

17.09%

Net cash growth

-37.76%

Net debt / EBITDA

-1.11

Net debt / equity

-0.09

Net debt / FCF

-3.37

Piotroski F-Score

Property, plant and equipment

AUD 55.1M

Shareholders' equity

AUD 390.9M

Tangible book value

AUD -69.2M

Tangible book value per share

AUD -0.85

Total assets

AUD 909.4M

Total cash

AUD 80M

Total debt

AUD 43.2M

Total liabilities

AUD 518.5M

WACC

10.03%

Metric	Value
Asset turnover	0.4
Current assets	AUD 339.5M
Current liabilities	AUD 259.9M
Current ratio	1.31
Inventory turnover	2.56
Net working capital	AUD 41.2M
Quick ratio	0.98
Working capital	AUD 79.5M
Working capital turnover	4.48

Metric

Value

Asset turnover

0.4

Current assets

AUD 339.5M

Current liabilities

AUD 259.9M

Current ratio

1.31

Inventory turnover

2.56

Net working capital

AUD 41.2M

Quick ratio

0.98

Working capital

AUD 79.5M

Working capital turnover

4.48

Metric	Value
Buyback yield / dilution	-34.3%
Dividend growth (10Y)	-26.61%
Dividend growth (3Y)	-64.34%
Dividend growth (5Y)	-46.14%
Dividend per share	AUD 0.00
Last dividend	AUD 0.03
Shareholder yield	-34.3%

Metric

Value

Buyback yield / dilution

-34.3%

Dividend growth (10Y)

-26.61%

Dividend growth (3Y)

-64.34%

Dividend growth (5Y)

-46.14%

Dividend per share

AUD 0.00

Last dividend

AUD 0.03

Shareholder yield

-34.3%

Metric	Value
10Y price change	-92.29%
10Y return CAGR	-21.6%
10Y total return	-91.23%
150-day SMA	AUD 2.70
15Y price change	-64.93%
15Y return CAGR	-3.83%
15Y total return	-44.37%
1D price change	8.68%
1M price change	-6.41%
1M total return	-6.41%
1W price change	3.54%
1W total return	3.54%
1Y price change	-56.96%
1Y return CAGR	-56.98%
1Y total return	-56.96%
20-day SMA	AUD 2.62
200-day SMA	AUD 2.67
3Y price change	-32.91%
3Y return CAGR	-12.45%
3Y total return	-32.91%
50-day SMA	AUD 2.88
50-day SMA vs 200-day SMA	50over200
52-week high	AUD 6.25
52-week high date	2025-10-29
52-week low	AUD 2.04
52-week low date	2026-03-20
5Y price change	-61.32%
5Y return CAGR	-15.15%
5Y total return	-56.01%
All-time high	AUD 42.20
All-time high date	2016-08-15
All-time low	AUD 0.22
All-time low date	2023-01-19
Average true range (ATR)	AUD 0.11
Average volume	110.2K
Beta (1Y)	0.31
Beta (2Y)	0.43
Beta (5Y)	1.03
Change from 52-week high	-57.92%
Change from 52-week low	28.92%
Change from all-time high	-93.77%
Change from all-time low	1,095.45%
Change from open	7.35%
Day's gap	1.24%
Dollar volume	AUD 287,406
High price	AUD 2.63
Low price	AUD 2.44
Monthly RSI	40.33
Open price	AUD 2.45
Position in 52-week range	100%
Previous close	AUD 2.42
Price vs 150-day SMA	-2.66%
Price vs 20-day SMA	0.31%
Price vs 200-day SMA	-1.57%
Price vs 50-day SMA	-8.62%
Relative volume	0.99
RSI	47.79
Sharpe ratio	-0.94
Sharpe ratio (3Y)	0.04
Sharpe ratio (5Y)	-0.03
Sortino ratio	-1.1
Sortino ratio (3Y)	0.15
Sortino ratio (5Y)	0.06
Volume	109.3K
Weekly RSI	44.78
YTD price change	-15.43%
YTD total return	-15.43%

Metric

Value

10Y price change

-92.29%

10Y return CAGR

-21.6%

10Y total return

-91.23%

150-day SMA

AUD 2.70

15Y price change

-64.93%

15Y return CAGR

-3.83%

15Y total return

-44.37%

1D price change

8.68%

1M price change

-6.41%

1M total return

-6.41%

1W price change

3.54%

1W total return

3.54%

1Y price change

-56.96%

1Y return CAGR

-56.98%

1Y total return

-56.96%

20-day SMA

AUD 2.62

200-day SMA

AUD 2.67

3Y price change

-32.91%

3Y return CAGR

-12.45%

3Y total return

-32.91%

50-day SMA

AUD 2.88

50-day SMA vs 200-day SMA

50over200

52-week high

AUD 6.25

52-week high date

2025-10-29

52-week low

AUD 2.04

52-week low date

2026-03-20

5Y price change

-61.32%

5Y return CAGR

-15.15%

5Y total return

-56.01%

All-time high

AUD 42.20

All-time high date

2016-08-15

All-time low

AUD 0.22

All-time low date

2023-01-19

Average true range (ATR)

AUD 0.11

Average volume

110.2K

Beta (1Y)

0.31

Beta (2Y)

0.43

Beta (5Y)

1.03

Change from 52-week high

-57.92%

Change from 52-week low

28.92%

Change from all-time high

-93.77%

Change from all-time low

1,095.45%

Change from open

7.35%

Day's gap

1.24%

Dollar volume

AUD 287,406

High price

AUD 2.63

Low price

AUD 2.44

Monthly RSI

40.33

Open price

AUD 2.45

Position in 52-week range

100%

Previous close

AUD 2.42

Price vs 150-day SMA

-2.66%

Price vs 20-day SMA

0.31%

Price vs 200-day SMA

-1.57%

Price vs 50-day SMA

-8.62%

Relative volume

0.99

RSI

47.79

Sharpe ratio

-0.94

Sharpe ratio (3Y)

0.04

Sharpe ratio (5Y)

-0.03

Sortino ratio

-1.1

Sortino ratio (3Y)

0.15

Sortino ratio (5Y)

0.06

Volume

109.3K

Weekly RSI

44.78

YTD price change

-15.43%

YTD total return

-15.43%

Metric	Value
Float	44.4M
Shares change (QoQ)	67.51%
Shares change (YoY)	34.3%
Shares held by insiders	19%
Shares held by institutions	33.64%
Shares outstanding	81.9M

Metric

Value

Float

44.4M

Shares change (QoQ)

67.51%

Shares change (YoY)

34.3%

Shares held by insiders

19%

Shares held by institutions

33.64%

Shares outstanding

81.9M

ASX/MYX (ASX/MYX)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/MYX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/MYX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/MYX

Frequently asked questions